A Phase I/II, Prospective Multi-Center Study of the Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Bone Marrow Cells in Chronic Ischemic Stroke

被引：0
|
作者：
Levy, Michael L.
Crawford, John
Dib, Nabil
Verkh, Lev
Tankovich, Nikolai
Cramer, Steven C.
机构：
来源：
NEUROSURGERY | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
168
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [1] Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke
    Levy, Michael L.
    Crawford, John R.
    Dib, Nabil
    Verkh, Lev
    Tankovich, Nikolai
    Cramer, Steven C.
    STROKE, 2019, 50 (10) : 2835 - 2841
  • [2] Safety and Efficacy of Bone Marrow Mesenchymal Stem Cells in the Treatment of Ischemic Stroke: A Meta-Analysis
    Zhang, Feng
    Wang, Yanyan
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2024, 27 (02) : 131 - 139
  • [3] Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study
    Awidi, Abdalla
    Al Shudifat, Abdulrahman
    El Adwan, Nael
    Alqudah, Mahmoud
    Jamali, Fatima
    Nazer, Fathy
    Sroji, Halla
    Ahmad, Hady
    Al-Quzaa, Nahla
    Jafar, Hanan
    CYTOTHERAPY, 2024, 26 (08) : 825 - 831
  • [4] Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial
    Vahidy, Putman S.
    Haque, Muhammad E.
    Rahbar, Mohammad H.
    Zhu, Hongjian
    Rowan, Paul
    Aisiku, Imoigele P.
    Lee, Dean A.
    Juneja, Harinder S.
    Alderman, Susan
    Barreto, Andrew D.
    Suarez, Jose, I
    Bambhroliya, Arvind
    Hasan, Khader M.
    Kassam, Mallikarjuna Rao
    Aronowski, Jaroslaw
    Gee, Adrian
    Cox, Charles S., Jr.
    Grotta, James C.
    Savitz, Sean, I
    STEM CELLS, 2019, 37 (11) : 1481 - 1491
  • [5] Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy Safety and Efficacy Results of a Phase II-A Randomized Trial
    Butler, Javed
    Epstein, Stephen E.
    Greene, Stephen J.
    Quyyumi, Arshed A.
    Sikora, Sergey
    Kim, Raymond J.
    Anderson, Allen S.
    Wilcox, Jane E.
    Tankovich, Nikolai I.
    Lipinski, Michael J.
    Ko, Yi-An
    Margulies, Kenneth B.
    Cole, Robert T.
    Skopicki, Hal A.
    Gheorghiade, Mihai
    CIRCULATION RESEARCH, 2017, 120 (02) : 332 - +
  • [6] A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
    Pawan K Gupta
    Anoop Chullikana
    Rajiv Parakh
    Sanjay Desai
    Anjan Das
    Sanjay Gottipamula
    Sagar Krishnamurthy
    Naveen Anthony
    Arun Pherwani
    Anish S Majumdar
    Journal of Translational Medicine, 11
  • [7] A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
    Gupta, Pawan K.
    Chullikana, Anoop
    Parakh, Rajiv
    Desai, Sanjay
    Das, Anjan
    Gottipamula, Sanjay
    Krishnamurthy, Sagar
    Anthony, Naveen
    Pherwani, Arun
    Majumdar, Anish S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [8] Phase I Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Interstitial Lung Disease in Patients with Connective Tissue Disorders
    Abril, Andy
    Mira-Avendano, Isabel
    Durand, Nisha
    Baig, Hassan
    Lee, Augustine
    Baer, Meghan
    Zubair, Abba
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2987 - 2989
  • [9] Phase I/II efficacy and safety study of mesenchymal stromal cells in recessive dystrophic epidermolysis bullosa
    Martinez-Santamaria, L.
    Maseda, R.
    Garcia, M.
    Chacon-Solano, E.
    Garcia-Barcenilla, S.
    Lwin, S. M.
    McGrath, J. A.
    del Rio, M.
    de Lucas, R.
    Escamez, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S236 - S236
  • [10] Phase II efficacy study of Dasatinib in patients with chronic and accelerated phase chronic myeloid leukaemia relapsing after allogeneic blood or bone marrow transplantation
    Olavarria, E.
    Chalandon, Y.
    Schleuning, M.
    Schattenberg, A.
    Michallet, M.
    Guglielmi, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S36 - S36
12345